āļŠāļāļļāļĨāđ€āļ‡āļīāļ™āļ„āļĢāļīāļ›āđ‚āļ•
āļ•āļąāļ§āļāļĨāļēāļ‡āļāļēāļĢāđāļĨāļāđ€āļ›āļĨāļĩāđˆāļĒāļ™
āļāļēāļĢāļ‹āļ·āđ‰āļ­āļ‚āļēāļĒāļŠāļīāļ™āļ—āļĢāļąāļžāļĒāđŒāļ”āļīāļˆāļīāļ—āļąāļĨāđ‚āļ”āļĒāļœāđˆāļēāļ™āļ„āļ™āļāļĨāļēāļ‡:
āļāļēāļĢāļ‹āļ·āđ‰āļ­āļ‚āļēāļĒāļŠāļīāļ™āļ—āļĢāļąāļžāļĒāđŒāļ”āļīāļˆāļīāļ—āļąāļĨāđ‚āļ”āļĒāđ„āļĄāđˆāļĄāļĩāļ„āļ™āļāļĨāļēāļ‡:

AstraZeneca PLC stock price
AZN
#38

āļŋ6,015.81
  

2.86%

AstraZeneca PLC Info

āļĄāļđāļĨāļ„āđˆāļēāļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒāļ•āļēāļĄāļĢāļēāļ„āļēāļ•āļĨāļēāļ”
āļŋ9.32T

2.86%

āļ›āļĢāļīāļĄāļēāļ“āļāļēāļĢāļ‹āļ·āđ‰āļ­āļ‚āļēāļĒāļĢāļēāļĒāļ§āļąāļ™
āļŋ16.4B
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒ
āļ›āļĢāļ°āđ€āļ āļ—āļŠāļīāļ™āļ—āļĢāļąāļžāļĒāđŒ
āļŦāļļāđ‰āļ™
āļžāļ™āļąāļāļ‡āļēāļ™
94300
āļāđˆāļ­āļ•āļąāđ‰āļ‡
Apr 6, 1999
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĩāđˆāđƒāļŠāđ‰āļ‹āļ·āđ‰āļ­āļ‚āļēāļĒ
Nasdaq
āļŦāļĄāļēāļĒāđ€āļĨāļ‚āļ›āļĢāļ°āļˆāļģāļ•āļąāļ§
0000901832

āļ‚āđ‰āļ­āļĄāļđāļĨāļŦāļļāđ‰āļ™āļ—āļĩāđˆāđāļ›āļĨāļ‡āđ€āļ›āđ‡āļ™āđ‚āļ—āđ€āļ„āļ™

āļĢāļēāļ„āļēāđ€āļ‰āļĨāļĩāđˆāļĒāļ‚āļ­āļ‡āļŠāļīāļ™āļ—āļĢāļąāļžāļĒāđŒāļ—āļĩāđˆāđāļ›āļĨāļ‡āđ€āļ›āđ‡āļ™āđ‚āļ—āđ€āļ„āļ™
āļŋ2.97K
āļ„āļ§āļēāļĄāļ•āđˆāļēāļ‡āļ‚āļ­āļ‡āļĢāļēāļ„āļē
+āļŋ3.03K(-50.52%)
āļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”āļ‚āļ­āļ‡āļŠāļīāļ™āļ—āļĢāļąāļžāļĒāđŒāđƒāļ™āļĢāļđāļ›āđāļšāļšāđ‚āļ—āđ€āļ„āļ™
āļŋ22.32M

0.35%

āļ›āļĢāļīāļĄāļēāļ“āļ‹āļ·āđ‰āļ­āļ‚āļēāļĒāļŠāļīāļ™āļ—āļĢāļąāļžāļĒāđŒāđƒāļ™āļĢāļđāļ›āđāļšāļšāđ‚āļ—āđ€āļ„āļ™ (24 āļŠ.āļĄ.
āļŋ20.2M

5.2%

āļœāļđāđ‰āļ­āļ­āļ
āļŠāļąāļāļāļē
āļŠāļģāļĢāļ§āļˆ
āļĢāļ°āļšāļšāđāļ›āļĨāļ‡ AZN āđ€āļ›āđ‡āļ™ USD
AZN
THB
āļāļēāļĢāļ›āļĢāļ°āđ€āļĄāļīāļ™āļ›āļĢāļ°āļŠāļīāļ—āļ˜āļīāļ āļēāļžāļ•āđˆāļ­āļĢāļēāļ„āļē
āļ•āđˆāļģ
āļŋ5.87K
āļŠāļđāļ‡
āļŋ6.09K

āļāļģāļĨāļąāļ‡āđ‚āļŦāļĨāļ”āļ‚āđ‰āļ­āļĄāļđāļĨ

āđ‚āļ›āļĢāļ”āļĢāļ­āļŠāļąāļāļ„āļĢāļđāđˆ āđ€āļĢāļēāļāļģāļĨāļąāļ‡āđ‚āļŦāļĨāļ”āļ‚āđ‰āļ­āļĄāļđāļĨāđāļœāļ™āļ āļđāļĄāļī

AstraZeneca PLC āļŠāļļāļĄāļŠāļ™

skeleton-white
 
 
 
 
 
 

About AstraZeneca PLC

What is AstraZeneca PLC?
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

āļ‚āđ‰āļ­āļĄāļđāļĨāļĢāļēāļ„āļēāļŠāļ” AstraZeneca PLC

The current price of AstraZeneca PLC in the market is āļŋ6,015.81, with a 24-hour trading volume of āļŋ16.4B. The asset's market cap is āļŋ9.32T, after moving 2.87% in the last day.

Tokenized AstraZeneca PLC is trading at āļŋ2,976.8, with a tokenized market cap of āļŋ22.32M and a 24-hour trading volume of āļŋ20.2M. The tokenized asset has moved 0.35% in the past 24 hours.